Cryo Cell International Inc (CCEL) Institutional Ownership

Ownership Summary

Cryo Cell International Inc (NYSE:CCEL) is held by 11 institutional investors per 13F filings through March 2026.

• Collectively, these holders controlled 358.1% of Cryo Cell International's outstanding shares in March 2026, down from 660.7% in December 2025.
• They increased total shares held in Cryo Cell International by 48.78% from last quarter, and the number of investors in CCEL decreased 50.0% annually.
• Of these 11 holders, 4 added to their stakes in Cryo Cell International, 2 trimmed positions, and 5 made no changes.
• Combined, these investors held 532.7K shares in CCEL for March 2026, up by 174.66K shares quarter on quarter, and down 498.12K shares year over year.
• SFI Advisors, LLC leads ownership in CCEL with 165.3K shares as of March 31, 2026, equal to 111.11% of outstanding shares.
• Top purchasers of CCEL stock for the quarter ending March 2026 included VANGUARD CAPITAL MANAGEMENT LLC (161.52K), VANGUARD FIDUCIARY TRUST CO (23.35K), BlackRock, Inc. (1.12K), UBS Group AG (459).
• The biggest sellers of Cryo Cell International for the quarter ending March 2026 included GEODE CAPITAL MANAGEMENT, LLC (9.55K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (2.24K).
• Cryo Cell International's 10 largest shareholders as of March 2026 include SFI Advisors, LLC (165.3K), VANGUARD CAPITAL MANAGEMENT LLC (161.52K), MassMutual Private Wealth & Trust, FSB (111.04K), GEODE CAPITAL MANAGEMENT, LLC (43.62K), VANGUARD FIDUCIARY TRUST CO (23.35K), BlackRock, Inc. (13.98K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (10.02K), OSAIC HOLDINGS, INC. (2.5K), UBS Group AG (672), Morgan Stanley (601) per Business Quant data.